BWAY

BrainsWay Ltd. American Depositary Shares (BWAY)

Stock · NASDAQ · Health Care

$11.42as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

BrainsWay Reports Expansion of TMS Insurance Coverage. BrainsWay announced that favorable insurance coverage for its Accelerated Deep TMS technology has expanded to over 70 million covered lives. This development is relevant as it potentially broadens the patient base for the company's devices. The stock is currently trading near its 52-week low, with an RSI of 30.3 indicating oversold conditions.

Active signals

Resistance level
$14.14
Industry
Medical/Dental Instruments

What BWAY's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike48-0.2%50%
Bollinger Band Breakout30+3.5%53%
Bollinger Band Breakdown15+7.6%53%
200-Day Moving Average TouchActive now3+12.7%100%
Any 20-session window (baseline)+2.9%55%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About BWAY

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzhei…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
129

Fundamentals

1-day range
$11.37$11.87
Market cap
$626.52M
P/E (trailing)
53.55
P/E (forward)
22.58
EPS (trailing)
$0.23
Dividend yield
—
Beta
0.96
Avg. volume
122.6K
52-week range
$2,391$5,123
Next earnings: November 10, 2026 · EPS estimate $0.09confirmed

Forecasts

3 analyst ratings

Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$20
+75.1%
Median
$19
+66.4%
Low
$18.8
+64.6%

BrainsWay Ltd. American Depositary Shares Competitors

Chosen by industry and closest market cap.

  • BWAY
    BrainsWay Ltd. American Depositary Shares
    $11.44
    ▼ 3.21%
    Market cap $626.52MP/E 53.55
    $2,391$5,123
  • ANGO
    AngioDynamics Inc. Common Stock
    $11.24
    ▼ 2.94%
    Market cap $624.53MP/E —
    $9.39$16.29
  • BBNX
    Beta Bionics Inc. Common Stock
    $16.35
    ▼ 5.55%
    Market cap $634.80MP/E —
    $8.8$32.71
  • MDXG
    MiMedx Group Inc Common Stock
    $4.43
    ▼ 5.34%
    Market cap $609.28MP/E 109.34
    $3.03$7.97
  • TCMD
    Tactile Systems Technology Inc. Common Stock
    $22.52
    ▼ 3.31%
    Market cap $650.97MP/E 21.02
    $14.43$37.77
  • KIDS
    OrthoPediatrics Corp. Common Stock
    $21.95
    ▼ 2.75%
    Market cap $549.03MP/E —
    $14.42$26.74
  • DCTH
    Delcath Systems Inc. Common Stock
    $14.08
    ▼ 4.93%
    Market cap $534.05MP/E 962.21
    $8.12$17.42

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
35.0K
Disposed
39.4K

Institutional Ownership

March 31, 2026

Total shares held
11.47M
Total value held
$140.51M
Institutional holders
53
Top holders this quarter
  • Unknown5.31M
  • Unknown1.65M
  • Unknown818.3K
  • Unknown618.6K
  • Unknown518.4K
  • Unknown314.9K
  • Unknown272.0K
  • Unknown226.4K
  • Unknown193.7K
  • Unknown172.6K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.